LOCAL FAILURE IN CHILDHOOD RHABDOMYOSARCOMA AND UNDIFFERENTIATED SARCOMA - PROGNOSTIC FACTORS AND IMPLICATIONS FOR CURATIVE THERAPY

被引:9
作者
MAMEGHAN, H
FISHER, R
TOBIAS, V
KERN, IB
OGORMANHUGHES, D
VOWELS, M
MAMEGHAN, J
机构
[1] PRINCE WALES HOSP, DEPT PEDIAT ANAT PATHOL, RANDWICK, NSW 2031, AUSTRALIA
[2] PRINCE WALES HOSP, DEPT PEDIAT SURG, RANDWICK, NSW 2031, AUSTRALIA
[3] PRINCE WALES HOSP, DEPT PAEDIAT HAEMATOL ONCOL, RANDWICK, NSW 2031, AUSTRALIA
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1993年 / 21卷 / 02期
关键词
RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; LOCAL FAILURE; SURVIVAL;
D O I
10.1002/mpo.2950210203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this retrospective review, the risk factors for local failure in childhood rhabdomyosarcoma and undifferentiated sarcoma were assessed in 49 patients managed by a multi-disciplinary team at the Prince of Wales Children's Hospital, Sydney, between 1970 and 1988. Average follow-up time was 6.1 years. Sixteen of 49 patients experienced local failure defined as local recurrence after complete excision (5/20) or progressive local disease following incomplete resection (11/29). Fourteen of 16 patients who experienced local failure have died. Using logrank analysis of time to local failure, we found significantly increased risk with ''non-embryonal'' histology (P = 0.032), residual tumour (P = 0.052, higher IRS group (P = 0.088), ''inadequate radiotherapy'' for residual tumour (P = 0.001), delay in definitive local treatment (P = 0.038) and Adriamycin-containing chemotherapy (P = 0.017). When these factors were examined by multivariate analysis (Cox regression), only the presence of residual tumour after resection, ''inadequate radiotherapy'' for residual tumour (P < 0.001), and delay in definitive local therapy (P = 0.037) were shown to have independent significant association with local failure. We conclude that local failure may be avoided by prompt local treatment by either complete surgical resection or adequate radiotherapy.
引用
收藏
页码:88 / 95
页数:8
相关论文
共 36 条
[1]   RHABDOMYOSARCOMA IN CHILDHOOD [J].
BALE, PM ;
REYE, RDK .
PATHOLOGY, 1975, 7 (02) :101-111
[2]   COVARIANCE ANALYSIS OF CENSORED SURVIVAL DATA [J].
BRESLOW, N .
BIOMETRICS, 1974, 30 (01) :89-99
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[4]  
ENZINGER FM, 1988, SOFT TISSUE TUMORS, P448
[5]  
GAIGER AM, 1981, NATL CANCER I MONOGR, V56, P19
[6]  
GHAVIMI F, 1975, CANCER, V35, P677, DOI 10.1002/1097-0142(197503)35:3<677::AID-CNCR2820350321>3.0.CO
[7]  
2-Y
[8]   RHABDOMYOSARCOMA IN CHILDHOOD - ANALYSIS OF SURVIVAL IN 98 CASES [J].
GROSFELD, JL ;
WEBER, TR ;
WEETMAN, RM ;
BAEHNER, RL .
JOURNAL OF PEDIATRIC SURGERY, 1983, 18 (02) :141-146
[9]   TREATMENT OF RHABDOMYOSARCOMA IN CHILDREN WITH SURGERY, RADIOTHERAPY AND CHEMOTHERAPY [J].
HEYN, R ;
HOLLAND, R ;
JOO, P ;
JOHNSON, D ;
NEWTON, W ;
TEFFT, M ;
BRESLOW, N ;
HAMMOND, D .
MEDICAL AND PEDIATRIC ONCOLOGY, 1977, 3 (01) :21-32
[10]  
HEYN RM, 1974, CANCER-AM CANCER SOC, V34, P2128, DOI 10.1002/1097-0142(197412)34:6<2128::AID-CNCR2820340638>3.0.CO